Astellas and seagen receive positive chmp opinion for padcev™ (enfortumab vedotin) in locally advanced or metastatic urothelial cancer

Tokyo and bothell, wash., dec. 17, 2021 /prnewswire/ -- astellas pharma inc. (tse:4503, president and ceo: kenji yasukawa, ph.d.

SGEN Ratings Summary

SGEN Quant Ranking